Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl V Clemons

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Archives of Microbiology|March 31, 2017
Effect of Anaerobiasis or Hypoxia on Pseudomonas aeruginosa Inhibition of Aspergillus fumigatus BiofilmRajesh Anand, Karl V Clemons, David A Stevens
Medical Mycology|July 9, 2010
Developing a vaccine against aspergillosisDavid A Stevens, Karl V Clemons, Min Liu
The Journal of Infectious Diseases|August 22, 2006
Interferon- gamma as an antifungalDavid A Stevens, Elmer Brummer, Karl V Clemons
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Advances in Experimental Medicine and Biology|November 22, 2015
Mycologic EndocrinologyKarl V Clemons, Jata Shankar, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Experimental animal models of coccidioidomycosisKarl V Clemons, Javier Capilla, David A Stevens
Medical Mycology|November 21, 2007
Animal models: an important tool in mycologyJavier Capilla, Karl V Clemons, David A Stevens
Medical Mycology|May 5, 2011
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosisKarl V Clemons, Julie A Schwartz, David A Stevens
Antimicrobial Agents and Chemotherapy|June 13, 2012
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicityKarl V Clemons, Julie A Schwartz, David A Stevens
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Archives of Microbiology|March 31, 2017
Effect of Anaerobiasis or Hypoxia on Pseudomonas aeruginosa Inhibition of Aspergillus fumigatus BiofilmRajesh Anand, Karl V Clemons, David A Stevens
Medical Mycology|July 9, 2010
Developing a vaccine against aspergillosisDavid A Stevens, Karl V Clemons, Min Liu
The Journal of Infectious Diseases|August 22, 2006
Interferon- gamma as an antifungalDavid A Stevens, Elmer Brummer, Karl V Clemons
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Advances in Experimental Medicine and Biology|November 22, 2015
Mycologic EndocrinologyKarl V Clemons, Jata Shankar, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Experimental animal models of coccidioidomycosisKarl V Clemons, Javier Capilla, David A Stevens
Medical Mycology|November 21, 2007
Animal models: an important tool in mycologyJavier Capilla, Karl V Clemons, David A Stevens
Medical Mycology|May 5, 2011
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosisKarl V Clemons, Julie A Schwartz, David A Stevens
Antimicrobial Agents and Chemotherapy|June 13, 2012
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicityKarl V Clemons, Julie A Schwartz, David A Stevens
Pageof 12